ArticleCancer medicine2020

Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab ("Pom-PAD-Dara") in relapsed/refractory multiple myeloma.

Xiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.